サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1426386

軟骨形成術の世界市場レポート 2024

Chondroplasty Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
軟骨形成術の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

軟骨形成術の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.8%の年間複合成長率（CAGR）で172億9,000万米ドルに成長すると予想されます。予測期間の成長は、再生医療の統合、外来治療への重点、新しい生体材料のイントロダクション、筋骨格系疾患の増加、および高齢者人口の拡大に起因すると考えられます。予測期間の主な動向には、リハビリテーションにおける技術統合、関節鏡技術の採用、軟骨修復と再生の進歩、手術器具の革新、ナビゲーションシステムの統合が含まれます。

予想される関節関連疾患の急増は、予見可能な将来の軟骨形成術市場の拡大を推進する触媒として機能します。これらの障害には、関節の機能に影響を与えるさまざまな健康上の問題が含まれており、多くの場合、過剰な関節の使用や、事故やスポーツ関連の事故などの突然の怪我に起因します。 軟骨形成術は、関節内の損傷した軟骨に対処することで、これらの関節関連疾患の治療として機能します。 2023年8月にランセット誌が発表した最近のデータは、英国で関節に影響を与える炎症性関節炎である痛風の発生率が増加していることを浮き彫りにしました。診断数は、2021年 3月の成人 1,000人あたり1.40人から、2022年 3月の成人 1,000人あたり1.44人に増加しました。さらに、2023年 6月の疾病管理予防センター（CDC）の予測では、2040年までに米国で約7,840万人（25.9%）が診断されると推定されています。 18歳以上の成人は医師の診断による関節炎（BRFSS）を受ける可能性があります。したがって、関節関連疾患の有病率のエスカレートは、軟骨形成術市場の成長軌道の原動力となっています。

膝の手術の増加により、今後の軟骨形成術市場の発展が促進される見込みです。膝の手術とは、膝の機能に影響を与えるさまざまな症状、損傷、障害に対処するために、膝関節を対象とした外科的介入を指します。 軟骨形成術は、関節内の損傷した軟骨の修復と再形成に重点を置いた外科手術であり、特に膝関連の治療に応用されています。注目すべきことに、国立医学図書館のデータによると、2022年に1150以上の施設で行われた股関節および膝関節手術の総数は2020年と比較して18.3%大幅に増加し、合計240万件の手術が行われたことが明らかになった。さらに、2023年1月の同ソースからの予測によると、2040年までに人工膝関節全置換術（TKA）が139%急増し、2060年までに469%急増すると予測されています。膝の手術が増加するにつれて、軟骨形成術の需要もそれに応じて押し上げられ、軟骨形成術市場の成長が促進されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の軟骨形成術市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 高周波アブレーション軟骨形成術
  • 剥離軟骨形成術
  • アテラ軟骨形成術
  • 半月板修復
  • 組織の除去
  • その他のタイプ
  • 世界の軟骨形成術市場、解剖学別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 膝
  • 肩
  • 腰
  • その他
  • 世界の軟骨形成術市場、装置別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • シェーバー
  • 高周波デバイス
  • 関節鏡
  • その他の設備
  • 世界の軟骨形成術市場、最終用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院
  • 整形外科クリニック
  • 学術研究
  • その他の最終用途

第7章 地域および国の分析

  • 世界の軟骨形成術市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の軟骨形成術市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 軟骨形成術市場の競合情勢
  • 軟骨形成術市場の企業プロファイル
    • Johnson &Johnson
    • F. Hoffmann-La Roche Ltd.
    • Osiris Therapeutics Inc.
    • Thermo Fisher Scientific Inc.
    • Takeda Pharmaceutical Company Limited

第31章 その他の大手および革新的な企業

  • Medtronic Public Limited Company
  • Stryker Corporation
  • Teva Pharmaceutical Industries Ltd.
  • B. Braun Melsungen AG
  • Zimmer Biomet Holdings Inc.
  • Smith &Nephew plc
  • Sigma-Aldrich Corporation
  • Arthrex Inc.
  • Bio-Rad Laboratories Inc
  • QIAGEN NV
  • CONMED Corporation
  • Promega Corporation
  • Organogenesis Holdings Inc.
  • Bioventus LLC
  • RTI Surgical Holdings Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13398

Chondroplasty is a surgical procedure designed to repair and reshape damaged cartilage within a joint, commonly performed to alleviate pain and improve joint function in cases of cartilage damage caused by conditions such as osteoarthritis or traumatic injuries.

The main types of chondroplasty include radiofrequency ablation chondroplasty, abrasion chondroplasty, patellar chondroplasty, meniscal repair, tissue removal, and others. Radiofrequency ablation chondroplasty targets minor imperfections in knee cartilage to minimize joint deterioration. Various anatomies, such as knee, shoulder, hip, and others, are addressed using tools such as shavers, radiofrequency devices, and arthroscopes. Chondroplasty procedures are performed in settings such as hospitals, orthopedic clinics, academic research institutions, and others.

The chondroplasty market research report is one of a series of new reports from The Business Research Company that provides chondroplasty market statistics, including chondroplasty industry global market size, regional shares, competitors with a chondroplasty market share, detailed chondroplasty market segments, market trends and opportunities, and any further data you may need to thrive in the chondroplasty industry. This chondroplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chondroplasty market size has grown strongly in recent years. It will grow from $12.92 billion in 2023 to $13.77 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to an increase in sports-related injuries, a preference among patients for non-total joint replacement, advances in postoperative care, enhanced training and expertise among healthcare providers, and a rising incidence of joint disorders.

The chondroplasty market size is expected to see strong growth in the next few years. It will grow to $17.29 billion in 2028 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to the integration of regenerative medicine, a focus on outpatient procedures, the introduction of novel biomaterials, the rise in musculoskeletal disorders, and the expansion of the geriatric population. Major trends in the forecast period include technological integration in rehabilitation, the adoption of arthroscopic techniques, advancements in cartilage repair and regeneration, innovations in surgical tools, and the integration of navigation systems.

The anticipated surge in joint-related disorders stands as a catalyst propelling the expansion of the chondroplasty market in the foreseeable future. These disorders encompass a range of health issues affecting joint functionality, often stemming from excessive joint use or abrupt injuries, such as accidents or sports-related incidents. Chondroplasty serves as a treatment for these joint-related disorders by addressing damaged cartilage within a joint. Recent data published by The Lancet in August 2023 highlighted a rise in the incidence of gout, an inflammatory arthritis impacting joints, in the UK. The diagnoses increased from 1.40 per 1,000 adults in March 2021 to 1.44 per 1,000 adults in March 2022. Furthermore, projections from the Centers for Disease Control and Prevention (CDC) in June 2023 estimate that by 2040, approximately 78.4 million (25.9%) US adults aged 18 years or older may receive doctor-diagnosed arthritis (BRFSS). Hence, the escalating prevalence of joint-related disorders is a driving force behind the chondroplasty market's growth trajectory.

The upswing in knee surgeries is poised to fuel the advancement of the chondroplasty market in the forthcoming period. Knee surgery denotes a surgical intervention targeting the knee joint to address a spectrum of conditions, injuries, or disorders impacting knee functionality. Chondroplasty, a surgical procedure focused on repairing and reshaping damaged cartilage within a joint, finds particular application in knee-related treatments. Notably, data from the National Library of Medicine revealed a substantial 18.3% increase in total hip and knee operations performed at over 1150 facilities in 2022 compared to 2020, totaling 2.4 million procedures. Moreover, projections from the same source in January 2023 indicate a projected surge of 139% in total knee arthroplasty (TKA) by 2040 and a striking 469% surge by 2060. As knee surgeries increase, the demand for chondroplasty is correspondingly boosted, fostering the growth dynamics of the chondroplasty market.

The prospective growth of the chondroplasty market has been hindered by limited reimbursement coverage for chondroplasty procedures. The existing reimbursement policies often impose restrictions on the frequency of chondroplasty treatments a patient can receive, posing challenges, particularly for individuals with recurring or extensive cartilage damage necessitating multiple procedures. Moreover, despite partial coverage, patients often face substantial out-of-pocket expenses, including deductibles, copayments, and coinsurance. These financial burdens may dissuade individuals, especially those facing financial constraints, from pursuing chondroplasty. An article published by the National Library of Medicine in December 2022 reported a concerning trend, a decrease in the average reimbursement rate per CPT code for hip arthroscopy procedures. In 2022, the rate dropped to $899.21, reflecting a notable decrease of $242.24 (21.1%) compared to the inflation-adjusted rate of $1,141.45 in 2011. This limited reimbursement coverage poses a significant obstacle to the expansion of the chondroplasty market.

Key players within the chondroplasty market are actively engaged in developing innovative technologies, such as articular cartilage segmentation tools, to enhance customer service offerings. An articular cartilage segmentation tool is a software application designed to automatically or semi-automatically segment articular cartilage from magnetic resonance imaging (MRI) scans. For example, in July 2021, RSIP Vision, an Israel-based software solution provider, introduced the Articular Cartilage Segmentation Tool. This cutting-edge tool leverages deep learning algorithms to automatically segment cartilage from MRI scans, delivering precise and non-invasive assessments of chondral lesions and cartilage-sparing procedures (such as mosaicplasty, micro-fracture, chondroplasty/osteochondral autograft transfer system, autologous chondrocyte implantation). Physicians utilizing RSIP Vision's module can more accurately evaluate an athlete's cartilage integrity, consequently offering optimal cartilage-sparing treatments. This leads to improved outcomes and shorter recovery times, amplifying the tool's potential to transform patient care within the chondroplasty domain.

In July 2023, Avanos Medical Inc., a prominent US-based company specializing in pain management and chronic care solutions, successfully completed the acquisition of Diros Technology Inc. for a sum totaling $60 million. This strategic acquisition serves to bolster Avanos' standing as a frontrunner in the realm of radiofrequency (RF) technology, expanding its portfolio with a comprehensive range of cutting-edge pain treatment devices. Diros Technology Inc., based in Canada, specializes in crafting radiofrequency devices tailored to address joint disorders such as knee, cervical, and lumbar pain. This acquisition marks a significant step for Avanos, enriching its offerings and solidifying its position within the industry by integrating Diros' expertise and unique devices into its product line.

Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc, QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.

North America was the largest region in the chondroplasty market in 2023. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chondroplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chondroplasty market includes revenues earned by entities by providing services such as microfracture surgery, laser-assisted treatments, and autologous chondrocyte transplantation (ACT). The market value includes the value of related goods sold by the service provider or included within the service offering. The chondroplasty market also includes sales of radiofrequency ablation devices and autologous chondrocyte implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chondroplasty Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chondroplasty market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chondroplasty? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chondroplasty market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Radiofrequency Ablation Chondroplasty; Abrasion Chondroplasty; Atellar Chondroplasty; Meniscal Repair; Tissue Removal; Other Types
  • 2) By Anatomy: Knee; Shoulder; Hip; Other Anatomies
  • 3) By Equipment: Shavers; Radiofrequency Devices; Arthroscope; Other Equipments
  • 4) By End Use: Hospitals; Orthopedic Clinics; Academic Research; Other End Uses
  • Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Osiris Therapeutics Inc.; Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chondroplasty Market Characteristics

3. Chondroplasty Market Trends And Strategies

4. Chondroplasty Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Chondroplasty Market Size and Growth

  • 5.1. Global Chondroplasty Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Chondroplasty Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Chondroplasty Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chondroplasty Market Segmentation

  • 6.1. Global Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Radiofrequency Ablation Chondroplasty
  • Abrasion Chondroplasty
  • Atellar Chondroplasty
  • Meniscal Repair
  • Tissue Removal
  • Other Types
  • 6.2. Global Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Knee
  • Shoulder
  • Hip
  • Other Anatomies
  • 6.3. Global Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Shavers
  • Radiofrequency Devices
  • Arthroscope
  • Other Equipments
  • 6.4. Global Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Orthopedic Clinics
  • Academic Research
  • Other End Use

7. Chondroplasty Market Regional And Country Analysis

  • 7.1. Global Chondroplasty Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Chondroplasty Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chondroplasty Market

  • 8.1. Asia-Pacific Chondroplasty Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chondroplasty Market

  • 9.1. China Chondroplasty Market Overview
  • 9.2. China Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chondroplasty Market

  • 10.1. India Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chondroplasty Market

  • 11.1. Japan Chondroplasty Market Overview
  • 11.2. Japan Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chondroplasty Market

  • 12.1. Australia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chondroplasty Market

  • 13.1. Indonesia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chondroplasty Market

  • 14.1. South Korea Chondroplasty Market Overview
  • 14.2. South Korea Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chondroplasty Market

  • 15.1. Western Europe Chondroplasty Market Overview
  • 15.2. Western Europe Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chondroplasty Market

  • 16.1. UK Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chondroplasty Market

  • 17.1. Germany Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chondroplasty Market

  • 18.5. France Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chondroplasty Market

  • 19.9. Italy Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chondroplasty Market

  • 20.13. Spain Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chondroplasty Market

  • 21.1. Eastern Europe Chondroplasty Market Overview
  • 21.2. Eastern Europe Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chondroplasty Market

  • 22.1. Russia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chondroplasty Market

  • 23.1. North America Chondroplasty Market Overview
  • 23.2. North America Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chondroplasty Market

  • 24.1. USA Chondroplasty Market Overview
  • 24.2. USA Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chondroplasty Market

  • 25.1. Canada Chondroplasty Market Overview
  • 25.2. Canada Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chondroplasty Market

  • 26.1. South America Chondroplasty Market Overview
  • 26.2. South America Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chondroplasty Market

  • 27.1. Brazil Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chondroplasty Market

  • 28.1. Middle East Chondroplasty Market Overview
  • 28.2. Middle East Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chondroplasty Market

  • 29.1. Africa Chondroplasty Market Overview
  • 29.2. Africa Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chondroplasty Market Competitive Landscape And Company Profiles

  • 30.1. Chondroplasty Market Competitive Landscape
  • 30.2. Chondroplasty Market Company Profiles
    • 30.2.1. Johnson & Johnson
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Osiris Therapeutics Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Thermo Fisher Scientific Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Takeda Pharmaceutical Company Limited
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Chondroplasty Market Other Major And Innovative Companies

  • 31.1. Medtronic Public Limited Company
  • 31.2. Stryker Corporation
  • 31.3. Teva Pharmaceutical Industries Ltd.
  • 31.4. B. Braun Melsungen AG
  • 31.5. Zimmer Biomet Holdings Inc.
  • 31.6. Smith & Nephew plc
  • 31.7. Sigma-Aldrich Corporation
  • 31.8. Arthrex Inc.
  • 31.9. Bio-Rad Laboratories Inc
  • 31.10. QIAGEN N.V.
  • 31.11. CONMED Corporation
  • 31.12. Promega Corporation
  • 31.13. Organogenesis Holdings Inc.
  • 31.14. Bioventus LLC
  • 31.15. RTI Surgical Holdings Inc.

32. Global Chondroplasty Market Competitive Benchmarking

33. Global Chondroplasty Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Chondroplasty Market

35. Chondroplasty Market Future Outlook and Potential Analysis

  • 35.1 Chondroplasty Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Chondroplasty Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Chondroplasty Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer